N. Eggmann

430 total citations
8 papers, 334 citations indexed

About

N. Eggmann is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, N. Eggmann has authored 8 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in N. Eggmann's work include Melanoma and MAPK Pathways (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Brain Metastases and Treatment (2 papers). N. Eggmann is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Brain Metastases and Treatment (2 papers). N. Eggmann collaborates with scholars based in Switzerland, United Kingdom and Italy. N. Eggmann's co-authors include Reinhard Dummer, Simone M. Goldinger, Jeannine D. Rinderknecht, Olivier Michielin, Christian P. Turtschi, Lada Mitchell, Paul R. Hilfiker, L. Véronèse, Lea Felderer and Marjam J. Barysch and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

N. Eggmann

8 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Eggmann Switzerland	5	195	193	154	54	52	8	334
Lea Felderer Switzerland	5	187 1.0×	266 1.4×	152 1.0×	55 1.0×	46 0.9×	6	359
Cyril Maire France	7	80 0.4×	103 0.5×	77 0.5×	12 0.2×	61 1.2×	26	280
Patrizia Maddalena Italy	7	102 0.5×	151 0.8×	26 0.2×	11 0.2×	44 0.8×	14	289
Silvia Buriolla Italy	6	138 0.7×	57 0.3×	99 0.6×	15 0.3×	7 0.1×	17	210
Kathleen Madden United States	9	165 0.8×	110 0.6×	107 0.7×	40 0.7×	3 0.1×	21	287
C. Billie Bian United States	4	122 0.6×	116 0.6×	110 0.7×	18 0.3×	2 0.0×	6	316
Ami Sabharwal United Kingdom	7	112 0.6×	183 0.9×	34 0.2×	92 1.7×	4 0.1×	14	266
Katja Lorenz Germany	6	183 0.9×	213 1.1×	22 0.1×	6 0.1×	29 0.6×	7	328
Lucie Heinzerling Germany	8	146 0.7×	70 0.4×	52 0.3×	13 0.2×	8 0.2×	22	210
Luca Paruzzo Italy	6	99 0.5×	71 0.4×	33 0.2×	18 0.3×	5 0.1×	12	192

Countries citing papers authored by N. Eggmann

Since Specialization

Citations

This map shows the geographic impact of N. Eggmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Eggmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Eggmann more than expected).

Fields of papers citing papers by N. Eggmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Eggmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Eggmann. The network helps show where N. Eggmann may publish in the future.

Co-authorship network of co-authors of N. Eggmann

This figure shows the co-authorship network connecting the top 25 collaborators of N. Eggmann. A scholar is included among the top collaborators of N. Eggmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Eggmann. N. Eggmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Dummer, Reinhard, Madeleine Duvic, Julia Scarisbrick, et al.. (2014). Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Annals of Oncology. 25(9). 1807–1812. 36 indexed citations

Dummer, Reinhard, Simone M. Goldinger, Christian P. Turtschi, et al.. (2013). Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study. European Journal of Cancer. 50(3). 611–621. 230 indexed citations

Eggmann, N., et al.. (2013). Subacute Cutaneous Lupus Erythematosus Triggered by Radiotherapy. Case Reports in Dermatology. 5(2). 232–235. 3 indexed citations

Kolm, Isabel, N. Eggmann, Jivko Kamarashev, et al.. (2013). Lichenoid Drug Eruptionfollowing Intravenous Applicationof Orally Formulated Diamorphine, a Semisynthetic Heroin. Case Reports in Dermatology. 5(2). 176–180. 15 indexed citations

Dummer, Reinhard, Sima Rozati, N. Eggmann, Jeannine D. Rinderknecht, & Simone M. Goldinger. (2012). From chemotherapy to targeted treatment. Annals of Oncology. 23. x101–x103. 4 indexed citations

Barysch, Marjam J., et al.. (2012). Long-Term Recurrence Rate of Large and Difficult to Treat Cutaneous Squamous Cell Carcinomas after Superficial Radiotherapy. Dermatology. 224(1). 59–65. 30 indexed citations

Dummer, Reinhard, Simone M. Goldinger, Christian P. Turtschi, et al.. (2012). Open-Label Pilot Study of Vemurafenib in Previously Treated Metastatic Melanoma (MM) Patients (PTS) with Symptomatic Brain Metastases (BM). Annals of Oncology. 23. ix366–ix366. 12 indexed citations

Goldinger, Simone M., Jeannine D. Rinderknecht, Benedetta Belloni, N. Eggmann, & Reinhard Dummer. (2012). Cutaneous side effects (cAE) of vemurafenib (V): Single-center cohort study of 28 metastatic melanoma (mM) patients (pts).. Journal of Clinical Oncology. 30(15_suppl). e19017–e19017. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact